Announced earlier this week, Indianapolis-based Eli Lilly and Co. is acquiring cancer-drug manufacturer ImClone. President and CEO John Lechleiter talks with Gerry about the $6.5 billion deal that has already been approved by the boards of both companies. Read more in our newsroom at http://www.insideindianabusiness.com/newsitem.asp?id=31859